XC8 in the Treatment of Patients With the Eosinophilic Phenotype of Bronchial Asthma
Clinical trial NCT04674137 · COMPLETED
Trial details
- NCT number
- NCT04674137
- Sponsor
- Chemlmmune Therapeutics LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-12-16
- Primary completion
- 2021-08-27
- Enrollment
- 70
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.